StockData
AstraZeneca PLC logo

AstraZeneca PLC

AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)

Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%

AstraZeneca Lokelma (sodium zirconium cyclosilicate) by Quarter

Lokelma (sodium zirconium cyclosilicate) — Europe product sales ($M) ($M)

QuarterlyAnnual

AstraZeneca Lokelma (sodium zirconium cyclosilicate): $47M in Q2 2026, up 56.7% from a year earlier. That is the highest of the 23 quarters on record here.

Latest, Q2 2026
47
Period ended Jun 30, 2026
Change on a year earlier
+56.7%
30 in Q2 2025
History
23 quarters
Since Q4 2020
Sources
23
Documents cited below

Where the Q2 2026 figure comes from

“|| Lokelma | 221 | | 26 | | 26 | | 85 | | 13 | | 48 | | 47 | | 40 | | 47 | | 54 | | 46 | | 41 | | 12 | | 22”

Source: Form 6-K FY2026Q2 Earnings Release ↗

Reported in Form 6-K / 20-F Product Sales Table.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedLokelma (sodium zirconium cyclosilicate) — Europe product sales ($M) ($M)Year on yearSource
Q2 2026Jun 30, 202647+56.7%Form 6-K FY2026Q2 Earnings Release ↗
Q1 2026Mar 31, 202641+57.7%Form 6-K FY2026Q1 Earnings Release ↗
Q4 2025Dec 31, 202538+46.2%Form 6-K FY2025Q4 Earnings Release ↗
Q3 2025Sep 30, 202535+40.0%Form 6-K FY2025Q3 Earnings Release ↗
Q2 2025Jun 30, 202530+30.4%Form 6-K FY2025Q2 Earnings Release ↗
Q1 2025Mar 31, 202526+44.4%Form 6-K FY2025Q1 Earnings Release ↗
Q4 2024Dec 31, 202426+52.9%Form 6-K FY2024Q4 Earnings Release ↗
Q3 2024Sep 30, 202425+56.3%Form 6-K FY2024Q3 Earnings Release ↗
Q2 2024Jun 30, 202423+64.3%Form 6-K FY2024Q2 Earnings Release ↗
Q1 2024Mar 31, 202418+63.6%Form 6-K FY2024Q1 Earnings Release ↗
Q4 2023Dec 31, 202317+88.9%Form 6-K FY2023Q4 Earnings Release ↗
Q3 2023Sep 30, 202316+100.0%Form 6-K FY2023Q3 Earnings Release ↗
Q2 2023Jun 30, 202314+100.0%Form 6-K FY2023Q2 Earnings Release ↗
Q1 2023Mar 31, 202311+83.3%Form 6-K FY2023Q1 Earnings Release ↗
Q4 2022Dec 31, 20229+80.0%Form 6-K FY2022Q4 Earnings Release ↗
Q3 2022Sep 30, 20228+166.7%Form 6-K FY2022Q3 Earnings Release ↗

Breakdown

What makes up lokelma (sodium zirconium cyclosilicate)

Cite this data

StockData. (2026). AstraZeneca Lokelma (sodium zirconium cyclosilicate) ($M), quarterly Q4 2020–Q2 2026 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/med-lokelma-eu

See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.

See a number that looks wrong?